Microbiology and Immunology

You are here

Home > Publications > Publications

Publications

Found 370 results
Author Title [ Type(Desc)] Year
Filters: First Letter Of Last Name is L  [Clear All Filters]
Journal Article
Lee JJin, Lee S-K, Song N, Nathan TO, Swarts BM, Eum S-Y, Ehrt S, Cho S-N, Eoh H.  2019.  Transient drug-tolerance and permanent drug-resistance rely on the trehalose-catalytic shift in Mycobacterium tuberculosis.. Nat Commun. 10(1):2928.
Coughlin CM, Salhany KE, Gee MS, LaTemple DC, Kotenko S, Ma X, Gri G, Wysocka M, Kim JE, Liu L et al..  1998.  Tumor cell responses to IFNgamma affect tumorigenicity and response to IL-12 therapy and antiangiogenesis.. Immunity. 9(1):25-34.
Coughlin CM, Salhany KE, Gee MS, LaTemple DC, Kotenko S, Ma X, Gri G, Wysocka M, Kim JE, Liu L et al..  1998.  Tumor cell responses to IFNgamma affect tumorigenicity and response to IL-12 therapy and antiangiogenesis.. Immunity. 9(1):25-34.
Coughlin CM, Salhany KE, Gee MS, LaTemple DC, Kotenko S, Ma X, Gri G, Wysocka M, Kim JE, Liu L et al..  1998.  Tumor cell responses to IFNgamma affect tumorigenicity and response to IL-12 therapy and antiangiogenesis.. Immunity. 9(1):25-34.
Coughlin CM, Salhany KE, Gee MS, LaTemple DC, Kotenko S, Ma X, Gri G, Wysocka M, Kim JE, Liu L et al..  1998.  Tumor cell responses to IFNgamma affect tumorigenicity and response to IL-12 therapy and antiangiogenesis.. Immunity. 9(1):25-34.
Elkon KB, Liu CC, Gall JG, Trevejo J, Marino MW, Abrahamsen KA, Song X, Zhou JL, Old LJ, Crystal RG et al..  1997.  Tumor necrosis factor alpha plays a central role in immune-mediated clearance of adenoviral vectors.. Proc Natl Acad Sci U S A. 94(18):9814-9.
Berro R, Sanders RW, Lu M, Klasse PJ, Moore JP.  2009.  Two HIV-1 variants resistant to small molecule CCR5 inhibitors differ in how they use CCR5 for entry.. PLoS Pathog. 5(8):e1000548.
Zhang L, Jiang X, Pfau D, Ling Y, Nathan CF.  2021.  Type I interferon signaling mediates Mycobacterium tuberculosis-induced macrophage death.. J Exp Med. 218(2)
Lam E, Falck-Pedersen E.  2014.  Unabated adenovirus replication following activation of the cGAS/STING-dependent antiviral response in human cells.. J Virol. 88(24):14426-39.
Alaedini A, Xiang Z, Kim H, Sung Y-J, Latov N.  2008.  Up-regulation of apoptosis and regeneration genes in the dorsal root ganglia during cisplatin treatment.. Exp Neurol. 210(2):368-74.
Amulic B, Salanti A, Lavstsen T, Nielsen MA, Deitsch KW.  2009.  An upstream open reading frame controls translation of var2csa, a gene implicated in placental malaria.. PLoS Pathog. 5(1):e1000256.
Murray HW, Tsai CW, Liu J, Ma X.  2006.  Visceral Leishmania donovani infection in interleukin-13-/- mice.. Infect Immun. 74(4):2487-90.
Lue NF, Hsu M.  2011.  A web of interactions at the ends.. Mol Cell. 42(3):269-71.
Darby CM, Ingólfsson HI, Jiang X, Shen C, Sun M, Zhao N, Burns K, Liu G, Ehrt S, J Warren D et al..  2013.  Whole cell screen for inhibitors of pH homeostasis in Mycobacterium tuberculosis.. PLoS One. 8(7):e68942.
Painter HJ, Altenhofen LM, Kafsack BFC, Llinás M.  2013.  Whole-genome analysis of Plasmodium spp. Utilizing a new agilent technologies DNA microarray platform.. Methods Mol Biol. 923:213-9.
Modarresi R, Xiang Z, Yin M, Laurence J.  2009.  WNT/beta-catenin signaling is involved in regulation of osteoclast differentiation by human immunodeficiency virus protease inhibitor ritonavir: relationship to human immunodeficiency virus-linked bone mineral loss.. Am J Pathol. 174(1):123-35.
Chasman DI, Lue NF, Buchman AR, LaPointe JW, Lorch Y, Kornberg RD.  1990.  A yeast protein that influences the chromatin structure of UASG and functions as a powerful auxiliary gene activator.. Genes Dev. 4(4):503-14.
Chasman DI, Lue NF, Buchman AR, LaPointe JW, Lorch Y, Kornberg RD.  1990.  A yeast protein that influences the chromatin structure of UASG and functions as a powerful auxiliary gene activator.. Genes Dev. 4(4):503-14.
Chasman DI, Lue NF, Buchman AR, LaPointe JW, Lorch Y, Kornberg RD.  1990.  A yeast protein that influences the chromatin structure of UASG and functions as a powerful auxiliary gene activator.. Genes Dev. 4(4):503-14.
Bosoy D, Lue NF.  2004.  Yeast telomerase is capable of limited repeat addition processivity.. Nucleic Acids Res. 32(1):93-101.